- Who We Are
- What We Do
- How To Help
- Contact Us
Gabrielle’s Angel Foundation funds cutting-edge research in the fields of leukemia, lymphoma, and related cancers of the blood.
We support research that focuses on cancer prevention, detection, and treatments that are most likely to be translated into clinical trials within a 3 – 5 year period. The Foundation not only funds mainstream scientific research but also projects that combine integrative (complementary) therapies or botanical agents. These annual Medical Research Awards total $225,000 and are given over a three-year period.
In recent years, the Foundation has expanded its reach to include the funding of select pediatric oncology initiatives, music therapy programs, as well as international projects. Gabrielle’s Angel Foundation has awarded grants totaling nearly $30 million in global giving and maintains its status as one of the largest non-governmental sources of grant support for blood cancer research in the nation.
ANNUAL REQUEST FOR PROPOSALS
Our invitation-only grant process is sent out annually each spring. Please consult your institution to see if you are eligible to apply. Submissions are due to the Foundation office in August after which they undergo rigorous peer review by the Foundation’s Medical Advisory Board.
This panel of experts, led by Stephen D. Nimer, MD, Director of the Sylvester Comprehensive Cancer Center, selects only the nation's most promising projects for funding. More than 80% of our grantees go on to obtain further funding thanks to early career support from Gabrielle’s Angel Foundation.
Determinations are made and all applicants notified by the end of each calendar year.
While working on submissions, qualified candidates may download and reference these Frequently Asked Questions. The guidelines are the same for both our Conventional and Integrative applicants, however, please reference this additional information for all Integrative Medicine proposals.
While we have funded research in the UK in years past, the Foundation is not currently accepting applications for consideration.